The therapeutic effect of PCSK9 inhibitors on dyslipidemia: one-year follow up

• 主要な著者: Maryam Moshkani Farahani (著者), Alireza Nasiri (著者), Mahdi Salari (著者), Ali Shamsedini (著者)
• フォーマット: 図書
• 出版事項: PAGEPress Publications, 2024-09-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Despite the availability of statins and lifestyle modifications, many patients with Dyslipidemia struggle to achieve optimal low-density lipoprotein cholesterol (LDL-C) control. PCSK9 inhibitors offer a promising new therapeutic option with superior LDL-C lowering efficacy compared to statins. Howev...